| scholarly article | Q13442814 |
| P50 | author | Gianfranco Sinagra | Q56650283 |
| P2093 | author name string | Frank I Marcus | |
| Francesca Brun | |||
| Luisa Mestroni | |||
| Kathleen Gear | |||
| Mark Borgstrom | |||
| Richard N Hauer | |||
| Judith A Groeneweg | |||
| Jeroen van der Heijden | |||
| Trina Hughes | |||
| P2860 | cites work | Use and misuse of surrogate outcomes in arrhythmia trials. | Q51271976 |
| Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q51625256 | ||
| Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q51674425 | ||
| Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. | Q53081386 | ||
| Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. | Q55638651 | ||
| Arrhythmogenic right ventricular cardiomyopathy | Q64043862 | ||
| [Prognosis and long-term development of arrhythmogenic dysplasia of the right ventricle] | Q72849364 | ||
| Epicardial ventricular tachycardia ablation a multicenter safety study | Q84269786 | ||
| Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention | Q84974205 | ||
| The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention | Q85812766 | ||
| Arrhythmogenic right ventricular dysplasia | Q86245500 | ||
| Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers | Q86783761 | ||
| Transthoracic epicardial catheter ablation: indications, techniques, and complications | Q26822582 | ||
| Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study | Q28238424 | ||
| Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study | Q30489889 | ||
| Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q33150735 | ||
| Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q33151854 | ||
| Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? | Q33153551 | ||
| Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up | Q33153601 | ||
| Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres | Q33155234 | ||
| Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia | Q33159168 | ||
| Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications | Q33162773 | ||
| Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: data from Italian ICD Registry for the years 2001-6. | Q33424947 | ||
| Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International S | Q34727600 | ||
| Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment | Q35735685 | ||
| Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? | Q36116944 | ||
| Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy | Q36426852 | ||
| Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. | Q37259910 | ||
| Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry | Q37357225 | ||
| Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. | Q37676235 | ||
| Long-term follow-up after sustained monomorphic ventricular tachycardia: Causes, pump failure, and empiric antiarrhythmic therapy that modify survival | Q43714717 | ||
| P433 | issue | 5 | |
| P921 | main subject | defibrillator | Q1450682 |
| P304 | page(s) | 558-564 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | JACC. Clinical electrophysiology | Q27726464 |
| P1476 | title | Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators | |
| P478 | volume | 2 |
Search more.